Background: This retrospective study is designed to evaluate factors affecting survival in a population of patients receiving pulmonary metastasectomy after gynecologic cancers. Methods: Nineteen patients with isolated lung metastases (one or two) were surgically treated with R0 resection. Four of them underwent lobectomies. Results: Six patients (31.6%) received adjuvant therapy and 11 (58%) experienced recurrences after metastasectomy. Five-and ten-year survival were 40.9% and 31.4%, respectively. Five-year survival in patients receiving adjuvant therapy was 52.4%. At multivariate analysis factors negatively influencing survival were a disease-free interval (DFI) of less than 24 months and recurrence after pulmonary metastasectomy. Conclusions: Pulmonary resection for metastatic gynecologic cancer is feasible and effective; adequate selection of patients is mandatory to achieve satisfactory results and long-term survival.

Pulmonary metastasectomy in uterine malignancies. Outcome and prognostic factors / Anile, Marco; Mantovani, Sara; Pecoraro, Ylenia; Carillo, Carolina; Gherzi, Lorenzo; Pagini, Andreina; Rendina, Erino Angelo; Venuta, Federico; Diso, Daniele. - In: JOURNAL OF THORACIC DISEASE. - ISSN 2072-1439. - STAMPA. - 9:Suppl 12(2017), pp. S1273-S1277. [10.21037/jtd.2017.07.46]

Pulmonary metastasectomy in uterine malignancies. Outcome and prognostic factors

Anile, Marco
;
Mantovani, Sara;Pecoraro, Ylenia;Carillo, Carolina;Gherzi, Lorenzo;Pagini, Andreina;Rendina, Erino Angelo;Venuta, Federico;Diso, Daniele
2017

Abstract

Background: This retrospective study is designed to evaluate factors affecting survival in a population of patients receiving pulmonary metastasectomy after gynecologic cancers. Methods: Nineteen patients with isolated lung metastases (one or two) were surgically treated with R0 resection. Four of them underwent lobectomies. Results: Six patients (31.6%) received adjuvant therapy and 11 (58%) experienced recurrences after metastasectomy. Five-and ten-year survival were 40.9% and 31.4%, respectively. Five-year survival in patients receiving adjuvant therapy was 52.4%. At multivariate analysis factors negatively influencing survival were a disease-free interval (DFI) of less than 24 months and recurrence after pulmonary metastasectomy. Conclusions: Pulmonary resection for metastatic gynecologic cancer is feasible and effective; adequate selection of patients is mandatory to achieve satisfactory results and long-term survival.
2017
Gynecologic cancer; Pulmonary metastasis; Survival; Pulmonary and Respiratory Medicine
01 Pubblicazione su rivista::01a Articolo in rivista
Pulmonary metastasectomy in uterine malignancies. Outcome and prognostic factors / Anile, Marco; Mantovani, Sara; Pecoraro, Ylenia; Carillo, Carolina; Gherzi, Lorenzo; Pagini, Andreina; Rendina, Erino Angelo; Venuta, Federico; Diso, Daniele. - In: JOURNAL OF THORACIC DISEASE. - ISSN 2072-1439. - STAMPA. - 9:Suppl 12(2017), pp. S1273-S1277. [10.21037/jtd.2017.07.46]
File allegati a questo prodotto
File Dimensione Formato  
Anile_Pulmonary-metastasectomy-uterine_2017.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 142.39 kB
Formato Adobe PDF
142.39 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1016369
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 7
social impact